1. Home
  2. BEAM vs AAT Comparison

BEAM vs AAT Comparison

Compare BEAM & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • AAT
  • Stock Information
  • Founded
  • BEAM 2017
  • AAT 1967
  • Country
  • BEAM United States
  • AAT United States
  • Employees
  • BEAM N/A
  • AAT N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • AAT Real Estate Investment Trusts
  • Sector
  • BEAM Health Care
  • AAT Real Estate
  • Exchange
  • BEAM Nasdaq
  • AAT Nasdaq
  • Market Cap
  • BEAM 1.9B
  • AAT 1.7B
  • IPO Year
  • BEAM 2020
  • AAT 2011
  • Fundamental
  • Price
  • BEAM $29.01
  • AAT $25.99
  • Analyst Decision
  • BEAM Buy
  • AAT Hold
  • Analyst Count
  • BEAM 10
  • AAT 2
  • Target Price
  • BEAM $47.67
  • AAT $26.00
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • AAT 352.0K
  • Earning Date
  • BEAM 11-05-2024
  • AAT 02-04-2025
  • Dividend Yield
  • BEAM N/A
  • AAT 5.15%
  • EPS Growth
  • BEAM N/A
  • AAT 17.42
  • EPS
  • BEAM N/A
  • AAT 0.97
  • Revenue
  • BEAM $349,643,000.00
  • AAT $452,499,000.00
  • Revenue This Year
  • BEAM N/A
  • AAT N/A
  • Revenue Next Year
  • BEAM $10.82
  • AAT $5.18
  • P/E Ratio
  • BEAM N/A
  • AAT $26.88
  • Revenue Growth
  • BEAM 328.73
  • AAT 5.13
  • 52 Week Low
  • BEAM $20.84
  • AAT $20.03
  • 52 Week High
  • BEAM $49.50
  • AAT $29.15
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 56.94
  • AAT 34.24
  • Support Level
  • BEAM $24.96
  • AAT $25.42
  • Resistance Level
  • BEAM $29.53
  • AAT $28.02
  • Average True Range (ATR)
  • BEAM 2.05
  • AAT 0.60
  • MACD
  • BEAM -0.04
  • AAT -0.29
  • Stochastic Oscillator
  • BEAM 67.05
  • AAT 18.04

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

Share on Social Networks: